461 – A Humanized Microfluidics BBB Model With Recirculation for CNS ARV Distribution Evaluation
Background Antiretroviral (ARV) efficacy in the central nervous system (CNS) is hindered by poor penetration across the blood–brain barrier (BBB). Current in vitro BBB models are limited by non-human or immortalized cells, few relevant cell types, and static conditions that restrict pharmacokinetic/pharmacodynamic (PK/PD) sampling. We developed a microfluidic BBB model with primary human brain cells…